Shanghai, China

Shengbin Zhang

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Fujian Akeylink Biotechnology Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shengbin Zhang. Retrieved from https://idiyas.com/inventor/shengbin-zhang-a6wpf494

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shengbin Zhang

Introduction

Shengbin Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compounds. His work focuses on innovative solutions for treating diseases related to ASK1.

Latest Patents

Shengbin Zhang holds a patent for a crystal form as an ASK1 inhibitor, along with its preparation method and application. This patent includes crystal forms A, B, C, and D of a compound of formula (I). The application of these crystal forms is aimed at the preparation of drugs for treating ASK1-related diseases.

Career Highlights

Zhang is currently employed at Fujian Akeylink Biotechnology Co., Ltd. His role at the company allows him to engage in cutting-edge research and development in the biotechnology sector. His innovative approach has positioned him as a key player in his field.

Collaborations

Shengbin Zhang collaborates with talented individuals such as Ning Li and Tao Yu. Their combined expertise enhances the research and development efforts at their company.

Conclusion

Shengbin Zhang's contributions to biotechnology and his innovative patent for ASK1 inhibitors highlight his importance in the field. His work continues to pave the way for advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…